Detail akcie Zimmer Hldgs online

Business Summary: Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Zimmer Biomet Holdings Inc revenues increased 7% to $7.39B. Net income before extraordinary items increased from $290.2M to $1.02B. Revenues reflect Americas segment increase of 8% to $4.62B, EMEA segment increase of 9% to $1.59B, Americas segment increase of 8% to $4.62B, EMEA segment increase of 9% to $1.59B. Net income benefited from Unallocated segment loss decrease of 15% to $1.62B.